David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFS
3026
Saul Centers
BFS
$844M
| $940K | ﹤0.01% |
23,430
+1,565
| +7% | +$55.6K |
|
|
GES
3027
PUT
DELISTED
Guess Inc
GES
| $940K | ﹤0.01% |
40,000
-80,000
| -67% | -$1.97M |
|
3028
PUT
Motorola Solutions
MSI
$80.3B
| $940K | ﹤0.01% |
5,000
| – | – |
|
|
HRC
3029
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $938K | ﹤0.01% |
8,491
-15,983
| -65% | -$1.67M |
|
|
QIWI
3030
DELISTED
QIWI PLC
QIWI
| $938K | ﹤0.01% |
88,085
-27,653
| -24% | -$296K |
|
3031
Rayonier Advanced Materials
RYAM
$582M
| $937K | ﹤0.01% |
103,310
-83,797
| -45% | -$721K |
|
3032
CALL
Buckle
BKE
$2.25B
| $935K | ﹤0.01% |
+23,800
| New | +$896K |
|
3033
Primis Financial Corp
FRST
$398M
| $935K | ﹤0.01% |
64,302
-23,266
| -27% | -$320K |
|
3034
PUT
Nabors Industries
NBR
$1.3B
| $935K | ﹤0.01% |
+10,000
| New | +$892K |
|
3035
CALL
Constellation Brands
STZ
$23.1B
| $935K | ﹤0.01% |
4,100
-27,600
| -87% | -$6.22M |
|
|
RPT
3036
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $935K | ﹤0.01% |
81,935
-212,975
| -72% | -$2.24M |
|
|
AXDX
3037
DELISTED
Accelerate Diagnostics
AXDX
| $931K | ﹤0.01% |
11,186
-2,700
| -19% | -$274K |
|
3038
Myers Industries
MYE
$1.23B
| $931K | ﹤0.01% |
47,137
-48,856
| -51% | -$1.05M |
|
3039
PUT
Inovio Pharmaceuticals
INO
$133M
| $928K | ﹤0.01% |
+8,333
| New | +$1.1M |
|
3040
CALL
Broadcom
AVGO
$1.7T
| $927K | ﹤0.01% |
+20,000
| New | +$925K |
|
|
SPR
3041
DELISTED
Spirit AeroSystems
SPR
| $926K | ﹤0.01% |
19,035
-364,302
| -95% | -$15.6M |
|
3042
Cushman & Wakefield Ltd
CWK
$3.49B
| $924K | ﹤0.01% |
56,598
+14,885
| +36% | +$233K |
|
3043
Financial Institutions
FISI
$800M
| $922K | ﹤0.01% |
30,454
-21,735
| -42% | -$587K |
|
3044
UFP Industries
UFPI
$4.89B
| $921K | ﹤0.01% |
12,139
-2,852
| -19% | -$179K |
|
3045
S&P Global
SPGI
$128B
| $920K | ﹤0.01% |
2,608
-186,052
| -99% | -$61.9M |
|
3046
Horizon Bancorp
HBNC
$1B
| $919K | ﹤0.01% |
49,437
-3,500
| -7% | -$62.2K |
|
3047
Burlington
BURL
$19.8B
| $918K | ﹤0.01% |
3,072
-10,774
| -78% | -$2.93M |
|
3048
Novanta
NOVT
$5.28B
| $916K | ﹤0.01% |
6,947
-5,962
| -46% | -$783K |
|
|
ARR
3049
CALL
Armour Residential REIT
ARR
$2.32B
| $915K | ﹤0.01% |
+15,000
| New | +$880K |
|
3050
CALL
Harley-Davidson
HOG
$2.86B
| $914K | ﹤0.01% |
+22,800
| New | +$848K |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.